Literature DB >> 28524762

Exosomes promote restoration after an experimental animal model of intracerebral hemorrhage.

Laura Otero-Ortega1, Mari Carmen Gómez de Frutos1, Fernando Laso-García1, Berta Rodríguez-Frutos1, Esperanza Medina-Gutiérrez1, Juan Antonio López2, Jesús Vázquez2, Exuperio Díez-Tejedor1, María Gutiérrez-Fernández1.   

Abstract

Exosomes are gaining importance because they show great promise in therapeutic applications for several diseases. Particularly in stroke, exosomes derived from mesenchymal stem cell (MSC) therapy work as paracrine effectors responsible for promoting neurovascular remodeling and functional recovery. Adult male rats were subjected to intracerebral hemorrhage (ICH) by intrastriatal injection of collagenase type IV; 24 h after surgery, MSC-derived exosomes were administered through the tail vein. The rats were euthanized at 7 or 28 days after treatment. Functional evaluation, lesion size, fiber tract integrity, axonal sprouting and white matter repair markers, biodistribution of exosomes and secretome proteomics were analyzed. DiI-labeled exosomes were found in the brains of the ICH-treated group and in the liver, lung and spleen. Animals receiving treatment with exosomes showed significantly better results in terms of functional recovery, lesion size, fiber tract integrity, axonal sprouting and white matter repair markers compared with the control group 28 days after stroke. Proteomics analysis of the exosomes identified more than 2000 proteins that could be implicated in brain repair function. In conclusion, white matter integrity was partly restored by exosome administration mediated by molecular repair factors. Exosomes as a treatment could be a heterogeneous process by nature and presents many factors that can influence brain plasticity in an adaptable and versatile manner.

Entities:  

Keywords:  Brain repair; exosome; intracerebral hemorrhage; subcortical stroke; white matter injury

Mesh:

Year:  2017        PMID: 28524762      PMCID: PMC5987932          DOI: 10.1177/0271678X17708917

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  35 in total

1.  Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury.

Authors:  Ruenn Chai Lai; Fatih Arslan; May May Lee; Newman Siu Kwan Sze; Andre Choo; Tian Sheng Chen; Manuel Salto-Tellez; Leo Timmers; Chuen Neng Lee; Reida Menshawe El Oakley; Gerard Pasterkamp; Dominique P V de Kleijn; Sai Kiang Lim
Journal:  Stem Cell Res       Date:  2010-01-04       Impact factor: 2.020

2.  Allogeneic bone marrow stromal cell transplantation after cerebral hemorrhage achieves cell transdifferentiation and modulates endogenous neurogenesis.

Authors:  Laura Otero; Mercedes Zurita; Celia Bonilla; Concepción Aguayo; Miguel A Rico; Alicia Rodríguez; Jesús Vaquero
Journal:  Cytotherapy       Date:  2011-09-23       Impact factor: 5.414

3.  Late transplantation of allogeneic bone marrow stromal cells improves neurologic deficits subsequent to intracerebral hemorrhage.

Authors:  Laura Otero; Mercedes Zurita; Celia Bonilla; Concepcion Aguayo; Angela Vela; Miguel A Rico; Jesus Vaquero
Journal:  Cytotherapy       Date:  2011-01-05       Impact factor: 5.414

4.  Microvesicles derived from human adult mesenchymal stem cells protect against ischaemia-reperfusion-induced acute and chronic kidney injury.

Authors:  Stefano Gatti; Stefania Bruno; Maria Chiara Deregibus; Andrea Sordi; Vincenzo Cantaluppi; Ciro Tetta; Giovanni Camussi
Journal:  Nephrol Dial Transplant       Date:  2011-02-15       Impact factor: 5.992

5.  Mouse intracerebral hemorrhage models produce different degrees of initial and delayed damage, axonal sprouting, and recovery.

Authors:  Harriet E Barratt; Tyler A Lanman; S Thomas Carmichael
Journal:  J Cereb Blood Flow Metab       Date:  2014-06-11       Impact factor: 6.200

6.  Exosomes mediate the cytoprotective action of mesenchymal stromal cells on hypoxia-induced pulmonary hypertension.

Authors:  Changjin Lee; S Alex Mitsialis; Muhammad Aslam; Sally H Vitali; Eleni Vergadi; Georgios Konstantinou; Konstantinos Sdrimas; Angeles Fernandez-Gonzalez; Stella Kourembanas
Journal:  Circulation       Date:  2012-10-31       Impact factor: 29.690

7.  MiR-133b promotes neural plasticity and functional recovery after treatment of stroke with multipotent mesenchymal stromal cells in rats via transfer of exosome-enriched extracellular particles.

Authors:  Hongqi Xin; Yi Li; Zhongwu Liu; Xinli Wang; Xia Shang; Yisheng Cui; Zheng Gang Zhang; Michael Chopp
Journal:  Stem Cells       Date:  2013-12       Impact factor: 6.277

8.  Bone marrow-derived mesenchymal stem cells ameliorate hepatic ischemia reperfusion injury in a rat model.

Authors:  Hiroyuki Kanazawa; Yasuhiro Fujimoto; Takumi Teratani; Junji Iwasaki; Naoya Kasahara; Kouji Negishi; Tatsuaki Tsuruyama; Shinji Uemoto; Eiji Kobayashi
Journal:  PLoS One       Date:  2011-04-29       Impact factor: 3.240

9.  Biomolecular characterization of exosomes released from cancer stem cells: Possible implications for biomarker and treatment of cancer.

Authors:  Dhruv Kumar; Dwijendra Gupta; Sharmila Shankar; Rakesh K Srivastava
Journal:  Oncotarget       Date:  2015-02-20

10.  GOrilla: a tool for discovery and visualization of enriched GO terms in ranked gene lists.

Authors:  Eran Eden; Roy Navon; Israel Steinfeld; Doron Lipson; Zohar Yakhini
Journal:  BMC Bioinformatics       Date:  2009-02-03       Impact factor: 3.169

View more
  59 in total

Review 1.  Exosome-mediated amplification of endogenous brain repair mechanisms and brain and systemic organ interaction in modulating neurological outcome after stroke.

Authors:  Poornima Venkat; Jieli Chen; Michael Chopp
Journal:  J Cereb Blood Flow Metab       Date:  2018-06-11       Impact factor: 6.200

2.  A gut feeling about stroke reveals gut-brain axis' active role in homeostasis and dysbiosis.

Authors:  Brooke Bonsack; Rays Hy Jiang; Cesar V Borlongan
Journal:  J Cereb Blood Flow Metab       Date:  2020-02-16       Impact factor: 6.200

3.  MiR-126 Mediates Brain Endothelial Cell Exosome Treatment-Induced Neurorestorative Effects After Stroke in Type 2 Diabetes Mellitus Mice.

Authors:  Poornima Venkat; Chengcheng Cui; Michael Chopp; Alex Zacharek; Fengjie Wang; Julie Landschoot-Ward; Yi Shen; Jieli Chen
Journal:  Stroke       Date:  2019-08-09       Impact factor: 7.914

Review 4.  Exosomes in perspective: a potential surrogate for stem cell therapy.

Authors:  Ke Ren
Journal:  Odontology       Date:  2018-10-15       Impact factor: 2.634

Review 5.  Astrocyte-derived extracellular vesicles: Neuroreparative properties and role in the pathogenesis of neurodegenerative disorders.

Authors:  Raghavendra Upadhya; Winston Zingg; Siddhant Shetty; Ashok K Shetty
Journal:  J Control Release       Date:  2020-04-11       Impact factor: 9.776

6.  Role of Exosomes Derived from miR-133b Modified MSCs in an Experimental Rat Model of Intracerebral Hemorrhage.

Authors:  Haitao Shen; Xiyang Yao; Haiying Li; Xiang Li; Tiejun Zhang; Qing Sun; Chengyuan Ji; Gang Chen
Journal:  J Mol Neurosci       Date:  2018-02-17       Impact factor: 3.444

Review 7.  Role of Exosomes as a Treatment and Potential Biomarker for Stroke.

Authors:  Laura Otero-Ortega; Fernando Laso-García; MariCarmen Gómez-de Frutos; Blanca Fuentes; Luke Diekhorst; Exuperio Díez-Tejedor; María Gutiérrez-Fernández
Journal:  Transl Stroke Res       Date:  2018-08-13       Impact factor: 6.829

Review 8.  Mesenchymal stromal cells for the treatment of ocular autoimmune diseases.

Authors:  Joo Youn Oh; Ryang Hwa Lee
Journal:  Prog Retin Eye Res       Date:  2021-03-26       Impact factor: 21.198

9.  Extracellular vesicles derived from bone marrow mesenchymal stem cells alleviate neuroinflammation after diabetic intracerebral hemorrhage via the miR-183-5p/PDCD4/NLRP3 pathway.

Authors:  H Ding; Y Jia; H Lv; W Chang; F Liu; D Wang
Journal:  J Endocrinol Invest       Date:  2021-05-23       Impact factor: 4.256

Review 10.  Exosomes - beyond stem cells for restorative therapy in stroke and neurological injury.

Authors:  Zheng Gang Zhang; Benjamin Buller; Michael Chopp
Journal:  Nat Rev Neurol       Date:  2019-04       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.